BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10914539)

  • 1. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.
    Largaespada DA
    Leukemia; 2000 Jul; 14(7):1174-84. PubMed ID: 10914539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
    Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of integrated murine leukemia viruses in a mouse model of acute myeloid leukemia by fluorescence in situ hybridization combined with tyramide signal amplification.
    Acar H; Copeland NG; Gilbert DJ; Jenkins NA; Largaespada DA
    Cancer Genet Cytogenet; 2000 Aug; 121(1):44-51. PubMed ID: 10958940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic profile of insertion mutations in mouse leukemias and lymphomas.
    Hansen GM; Skapura D; Justice MJ
    Genome Res; 2000 Feb; 10(2):237-43. PubMed ID: 10673281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
    Rodenburg M; Fischer M; Engelmann A; Harbers SO; Ziegler M; Löhler J; Stocking C
    J Virol; 2007 Jan; 81(2):732-42. PubMed ID: 17079317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4.
    Kone J; Arroyo J; Savinelli T; Lin S; Boyd K; Wu Y; Nimmakayalu M; Copeland NG; Jenkins NA; Qumsiyeh M; Hu P; Prescott A; Wu H; Yang L; Roe B; Perkins AS
    Leukemia; 2002 Sep; 16(9):1827-34. PubMed ID: 12200699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
    Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
    Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
    Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
    Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale identification of disease genes involved in acute myeloid leukemia.
    Erkeland SJ; Valkhof M; Heijmans-Antonissen C; van Hoven-Beijen A; Delwel R; Hermans MH; Touw IP
    J Virol; 2004 Feb; 78(4):1971-80. PubMed ID: 14747562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia.
    Haeri M; Li Y; Li Y; Li Q; Spaner DE; Ben-David Y
    Int J Oncol; 2013 Jul; 43(1):169-76. PubMed ID: 23677281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of an oncogenic microRNA cistron by provirus integration.
    Wang CL; Wang BB; Bartha G; Li L; Channa N; Klinger M; Killeen N; Wabl M
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18680-4. PubMed ID: 17121985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis and characterization of two myeloid leukemia inducing murine retroviruses.
    Rassart E; Houde J; Denicourt C; Ru M; Barat C; Edouard E; Poliquin L; Bergeron D
    Curr Top Microbiol Immunol; 1996; 211():201-10. PubMed ID: 8585951
    [No Abstract]   [Full Text] [Related]  

  • 14. Rmcf2, a xenotropic provirus in the Asian mouse species Mus castaneus, blocks infection by polytropic mouse gammaretroviruses.
    Wu T; Yan Y; Kozak CA
    J Virol; 2005 Aug; 79(15):9677-84. PubMed ID: 16014929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
    Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operating under a Gag order: a block against incoming virus by the Fv1 gene.
    Goff SP
    Cell; 1996 Sep; 86(5):691-3. PubMed ID: 8797814
    [No Abstract]   [Full Text] [Related]  

  • 17. Host range conversion of murine leukemia virus resulting from recombination with endogenous virus.
    Kawana A; Iwamoto A; Odawara T; Yoshikura H
    Arch Virol; 1997; 142(1):139-49. PubMed ID: 9155878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia.
    Erkeland SJ; Verhaak RG; Valk PJ; Delwel R; Löwenberg B; Touw IP
    Cancer Res; 2006 Jan; 66(2):622-6. PubMed ID: 16423987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
    J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of a mouse serum lipoprotein factor that inactivates murine leukemia viruses: evaluation of apolipoprotein F as a candidate.
    Wu T; Lee CG; Buckler-White A; Kozak CA
    J Virol; 2002 Mar; 76(5):2279-86. PubMed ID: 11836406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.